Personal Patient Profile Prostate (P4) Randomized, Multisite Trial
N/A
21 Years
N/A
21 Years
N/A
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
Personal Patient Profile Prostate (P4) Randomized, Multisite Trial
Inclusion Criteria:
- Biopsy-proven diagnosis of prostate cancer, stage I or II
- Diagnosis within the past 6 months
- Has appointment with a consulting specialist at one of the clinical trial sites
- Must be able to read and write English or Spanish at a 6th grade level
- Must not have begun any treatment (except watchful waiting)
- Must be able to complete baseline assessment before target clinician visit.
Exclusion Criteria:
- Advanced prostate cancer
- Diagnosed more than 6 months ago
- Cannot read and write English or Spanish at a 6th grade level
- Does not have appointment at one of the clinical trial sites
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Outcome Measure:
Decisional Conflict
Outcome Time Frame:
Baseline to 6 months
Safety Issue:
No
Principal Investigator
Seth Wolpin, RN, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Washington
Authority:
United States: Federal Government
Study ID:
1 R01 NR009692
NCT ID:
NCT00692653
Start Date:
February 2007
Completion Date:
December 2009
Related Keywords:
- Prostate Cancer
- Localized prostate cancer
- Treatment decision making
- Tailored decision aid
- Prostatic Neoplasms
Name | Location |
|---|---|
| Fox Chase Cancer Center | Philadelphia, Pennsylvania 19111 |
| University of Washington Medical Center | Seattle, Washington 98195-6043 |
| University of Texas Health Sciences Center at San Antonio | San Antonio, Texas 78229 |
| Veterans Administration Puget Sound Health Care System | Seattle, Washington 98108-1597 |
| Seattle Prostate Institute | Seattle, Washington 98104 |
| VA Medical Center / Medical College of Georgia | Augusta, Georgia 30904 |
